MARKET

ANIP

ANIP

Ani Pharmaceutic
NASDAQ
76.90
+3.19
+4.33%
After Hours: 76.90 0 0.00% 16:20 03/31 EDT
OPEN
74.27
PREV CLOSE
73.71
HIGH
77.36
LOW
74.27
VOLUME
372.05K
TURNOVER
--
52 WEEK HIGH
99.50
52 WEEK LOW
56.71
MARKET CAP
1.72B
P/E (TTM)
23.13
1D
5D
1M
3M
1Y
5Y
1D
RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease
NASDAQ · 1d ago
Weekly Report: what happened at ANIP last week (0323-0327)?
Weekly Report · 1d ago
ANI Pharmaceuticals (ANIP) Receives a Rating Update from a Top Analyst
TipRanks · 6d ago
IBRX Stock Slides on FDA Warning Over Misleading Cancer Drug Claims
NASDAQ · 6d ago
VALN Stock Nosedives on Mixed Results From Lyme Disease Vaccine Study
NASDAQ · 03/24 16:12
Weekly Report: what happened at ANIP last week (0316-0320)?
Weekly Report · 03/23 09:29
Encompass Health Expands in Delaware With New 40-Bed Unit Plans
NASDAQ · 03/19 18:13
Barclays Keeps Their Buy Rating on ANI Pharmaceuticals (ANIP)
TipRanks · 03/19 08:36
More
About ANIP
ANI Pharmaceuticals, Inc. is a diversified biopharmaceutical company engaged in developing, manufacturing, and commercializing therapeutics. Its Rare Disease and Brands segment consists of two reporting units. The Rare Disease unit consists of operations related to the development, manufacturing, and marketing of branded pharmaceutical products, with a focus on products used in the treatment of patients with rare disease conditions and consists of operations related to Cortrophin Gel, ILUVIEN and YUTIQ. In addition, the Brands reporting unit includes a portfolio of over 16 brand products that are principally sold in genericized markets. Its Generics and Other segment consist of operations related to the development, manufacturing, and marketing of generic pharmaceutical products, including those sold through traditional wholesale and retail sales channels, sales of contract manufactured products, royalties on contract manufactured products, product development services, and others.

Webull offers ANI Pharmaceuticals Inc stock information, including NASDAQ: ANIP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIP stock methods without spending real money on the virtual paper trading platform.